TABLE 3.
Characteristic | Category | No. of Cases | % of Cases |
---|---|---|---|
Response | Complete Response | 1 | 1.9 |
Partial Response | 7 | 13.5 | |
Stable Disease | 34 | 65.4 | |
Increasing Disease | 8 | 15.4 | |
Indeterminate | 2 | 3.8 | |
Cycles of Treatment | 1 | 7 | 13.5 |
2 | 8 | 15.4 | |
3 | 6 | 11.5 | |
4 | 5 | 9.6 | |
5 | 1 | 1.9 | |
6 | 2 | 3.8 | |
7 | 2 | 3.8 | |
10 | 4 | 7.7 | |
12 | 2 | 3.8 | |
13 | 1 | 1.9 | |
14 | 3 | 5.8 | |
15 | 2 | 3.8 | |
>15† | 9 | 17.3 | |
Alive‡ | Without progression | 10 | 19.2 |
With progression | 22 | 42.3 | |
Dead‡ | From disease | 17 | 32.7 |
From neither Rx nor disease | 1 | 1.9 | |
From undetermined cause | 1 | 1.9 | |
Pending | 1 | 1.9 |
Three patients remain on study therapy (after receiving 20, 33, and 35 cycles).
As of database lock, May 16, 2011.